SCHEMBL20752134

SCHEMBL20752134

CNc1nc(Nc2cc(OC)cc(-n3nnnc3C)c2)ncc1Cl

nearest known ligand 0.58

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
PRKCQ Q04759 8/20 0.58
LRRK2 Q5S007 10/20 0.53
BRD4 O60885 2/20 0.51
JAK2 O60674 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20752168 0.90 PRKCQ (0.59) PRKCQLRRK2BRD4JAK2
SCHEMBL20752081 0.89 PRKCQ (0.59) PRKCQLRRK2BRD4
SCHEMBL20752186 0.86 PRKCQ (0.56) PRKCQLRRK2BRD4JAK2
SCHEMBL20752181 0.85 LRRK2 (0.62) PRKCQLRRK2
SCHEMBL20752144 0.85 PRKCQ (0.55) PRKCQLRRK2
SCHEMBL20752152 0.81 LRRK2 (0.61) LRRK2BRD4JAK2
SCHEMBL20752239 0.81 LRRK2 (0.55) LRRK2BRD4JAK2
SCHEMBL20752079 0.81 PRKCQ (0.51) PRKCQ
SCHEMBL15769573 0.80 PRKCQ (0.62) PRKCQBRD4JAK2
SCHEMBL20752295 0.79 LRRK2 (0.51) PRKCQLRRK2JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2928891-B1 PROTEIN KINASE C INHIBITORS AND USES THEREOF RIGEL PHARMACEUTICALS INC (US) 2019-02-20 EP disclosed